RE: IG droup25 Feb 2021 14:02
about all we know; Big profits next year, ahem, cough!
''Recent investments in the Group's UK-based Genomic Services offering and adaptation to constrained international mobility through the recruitment of in-territory commercial and support teams in North America, mainland Europe and South East Asia, coupled with the lower than expected revenue growth, mean that significant profitability improvements expected in the current financial year are now expected to be realised in the next financial year. Guidance on COVID-19 testing related revenues, by contrast, had been forecast to the end of March 2021 only, whereas these are now expected to make a significant contribution to the next financial year''.